- Home
- Products
- Customized FluoroAb™
- ERBB3
- Anti-ERBB3 MAb (Clone 2)-iFluor® 488 Succinimidyl Ester
Anti-ERBB3 MAb (Clone 2)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS9444)
This product is comprised of an Humanized Anti-ERBB3 IgG2-lambda antibody (Clone 2) labeled with iFluor® 488 Succinimidyl Ester. iFluor® 488 Succinimidyl Ester is a Green-fluorescent dye and it's excitation/emission is 403/427 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- ERBB3
- Alternative Names
- ERBB3; v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian); LCCS2; lethal congenital contracture syndrome 2; receptor tyrosine-protein kinase erbB-3; HER3; proto-oncogene-like protein c-ErbB-3; tyrosine kinase-type cell surface receptor HER3; LCCS2; ErbB-3; c-erbB3; erbB3-S; MDA-BF-1; c-erbB-3; p180-ErbB3; p45-sErbB3; p85-sErbB3; MGC88033;
- Overview
- This gene encodes a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases. This membrane-bound protein has a neuregulin binding domain but not an active kinase domain. It therefore can bind this ligand but not convey the signal into the cell through protein phosphorylation. However, it does form heterodimers with other EGF receptor family members which do have kinase activity. Heterodimerization leads to the activation of pathways which lead to cell proliferation or differentiation. Amplification of this gene and/or overexpression of its protein have been reported in numerous cancers, including prostate, bladder, and breast tumors. Alternate transcriptional splice variants encoding different isoforms have been characterized. One isoform lacks the intermembrane region and is secreted outside the cell. This form acts to modulate the activity of the membrane-bound form. Additional splice variants have also been reported, but they have not been thoroughly characterized.
- Overview
- Humanized Anti-ERBB3 IgG2-lambda antibody (Clone 2)
- Species Reactivity
- Human
- Name
- iFluor® 488 Succinimidyl Ester
- Color
- Green
- Excitation⁄Emission (nm)
- 491/516
- Detection method
- Fluorescent
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-MUC16 MAb (Clone 8)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS6681)
- Anti-ITGB2 MAb (Clone 4)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS10604)
- Anti-IL17RA MAb (Clone 1)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8312)
- Priliximab-Fluoresein (CAT#: ADC-FL-646)
- Anti-MYL MAb (Clone 9)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13914)
- Anti-MSTN MAb (Clone 4)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS6819)
- Anti-MUC1 MAb (Clone 11)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS10026)
- Anti-TNFRSF17 MAb (Clone 9)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14220)
- Anti-PCSK9 MAb (Clone 6)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS12208)
- Anti-CD19 MAb (Clone 12)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5425)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS9444. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-2366 | Anti-ERBB3 (Duligotuzumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-1127 | Anti-ERBB3 (Seribantumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-2241 | Anti-ERBB3 (Duligotumab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
| ADC-W-2368 | Anti-ERBB3 (Duligotuzumab)-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
| ADC-W-2243 | Anti-ERBB3 (Duligotumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.